For example, miR-30a, when upregulated in nasopharyngeal carcinoma cells, appears to be capable of reducing SOX2 protein by targeting the 3’ UTR of SOX2 mRNA [155]. This evidence concerns the gene SOX2 and nasopharyngeal carcinoma.